Keyphrases
Cytomegalovirus Infection
100%
Valganciclovir
100%
Antiviral Resistance
100%
UL97
40%
Ganciclovir
20%
Virus
20%
Congenital Infection
20%
Antiretroviral Therapy
20%
Cytomegalovirus
20%
Neurodevelopmental Outcome
20%
Viral Load
20%
Sudden Sensorineural Hearing Loss (SSNHL)
20%
Human Cytomegalovirus
20%
DNAemia
20%
Auditory Outcomes
20%
Phosphotransferase
20%
Contrastive Analysis
20%
Oral Therapy
20%
Newborn Dried Blood Spots
20%
Ganciclovir Resistance
20%
Oral Prodrugs
20%
Fold Increase
20%
Proviral DNA
20%
Viral Variants
20%
Virological Monitoring
20%
Medicine and Dentistry
Congenital Cytomegalovirus Infection
100%
Antiviral Resistance
100%
Valganciclovir
100%
Neonatal Infant
40%
Ganciclovir
40%
Congenital Infection
20%
Virus
20%
Phosphotransferase
20%
Virus DNA
20%
Cytomegalovirus
20%
Sensorineural Hearing Loss
20%
Antiviral Therapy
20%
Human Cytomegalovirus
20%
Dried Blood Spot
20%
Prodrug
20%